Quoin Pharmaceuticals Ltd. (QNRX)
6.93
-0.04
(-0.57%)
USD |
NASDAQ |
Sep 10, 16:00
6.93
0.00 (0.00%)
After-Hours: 16:26
Quoin Pharmaceuticals Net Income (Quarterly) : -5.463M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.463M |
| March 31, 2026 | -4.984M |
| December 31, 2025 | -4.376M |
| September 30, 2025 | -3.967M |
| June 30, 2025 | -3.775M |
| March 31, 2025 | -3.792M |
| December 31, 2024 | -2.330M |
| September 30, 2024 | -2.357M |
| June 30, 2024 | -1.967M |
| March 31, 2024 | -2.353M |
| December 31, 2023 | -2.072M |
| September 30, 2023 | -1.920M |
| June 30, 2023 | -2.083M |
| March 31, 2023 | -2.579M |
| December 31, 2022 | -1.996M |
| September 30, 2022 | -3.005M |
| June 30, 2022 | -2.637M |
| March 31, 2022 | -1.686M |
| December 31, 2021 | -11.87M |
| September 30, 2021 | -1.411M |
| June 30, 2021 | -4.356M |
| March 31, 2021 | -3.863M |
| December 31, 2020 | -1.026M |
| September 30, 2020 | -0.3307M |
| June 30, 2020 | -2.508M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.7295M |
| December 31, 2019 | -1.740M |
| September 30, 2019 | -1.365M |
| June 30, 2019 | -0.227M |
| March 31, 2019 | -1.401M |
| December 31, 2018 | -1.013M |
| September 30, 2018 | -1.871M |
| June 30, 2018 | -1.674M |
| March 31, 2018 | -1.033M |
| December 31, 2017 | -0.9636M |
| September 30, 2017 | -2.192M |
| June 30, 2017 | -1.297M |
| March 31, 2017 | -3.385M |
| December 31, 2016 | -0.7503M |
| September 30, 2016 | -1.436M |
| June 30, 2016 | -0.8345M |
| March 31, 2016 | -0.9789M |
| December 31, 2015 | -0.9512M |
| September 30, 2015 | -0.6517M |
| June 30, 2015 | -0.557M |
| March 31, 2015 | -0.461M |
| December 31, 2014 | -0.4855M |
| September 30, 2014 | -0.4625M |
| June 30, 2014 | -0.3937M |
| March 31, 2014 | -0.192M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.463M |
| EPS Diluted (Quarterly) | -2.720 |
| Enterprise Value | 3.198M |
| Earnings Yield | -215.4% |
| Normalized Earnings Yield | -215.49 |